Variant report
Variant | nsv429981 |
---|---|
Chromosome Location | chr9:1500755-1513917 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr9:1492000..1494748-chr9:1498884..1501267,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs7047146 | chr9:1500755-1500756 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs181271695 | chr9:1500762-1500763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs575608176 | chr9:1500764-1500765 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs544181974 | chr9:1500766-1500767 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs112810040 | chr9:1500794-1500795 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs531294498 | chr9:1500831-1500832 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs79407968 | chr9:1500843-1500844 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs34400667 | chr9:1500856-1500857 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs540297687 | chr9:1500874-1500875 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs74632110 | chr9:1500907-1500908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs555477619 | chr9:1500937-1500938 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542801246 | chr9:1500941-1500942 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs562788020 | chr9:1500953-1500954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73640484 | chr9:1500985-1500986 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs79416772 | chr9:1501020-1501021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs571582193 | chr9:1501032-1501033 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146948750 | chr9:1501066-1501067 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547797400 | chr9:1501067-1501068 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs567754650 | chr9:1501092-1501093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536791130 | chr9:1501095-1501096 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10756625 | chr9:1501109-1501110 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs77950785 | chr9:1501117-1501118 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs115317255 | chr9:1501138-1501139 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs147725934 | chr9:1501143-1501144 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs577899377 | chr9:1501149-1501150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539833967 | chr9:1501154-1501155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs373701299 | chr9:1501212-1501213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs567125138 | chr9:1501213-1501214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553390794 | chr9:1501216-1501217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs573396590 | chr9:1501219-1501220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs75646864 | chr9:1501251-1501252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs559662219 | chr9:1501269-1501270 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs201589184 | chr9:1501272-1501273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs371746333 | chr9:1501319-1501320 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182978710 | chr9:1501328-1501329 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs149179794 | chr9:1501386-1501387 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs545654869 | chr9:1501421-1501422 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs565416893 | chr9:1501433-1501434 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs557368462 | chr9:1501446-1501447 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs55770609 | chr9:1501449-1501450 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs58498719 | chr9:1501459-1501460 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs62534837 | chr9:1501469-1501470 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
43 | rs530176955 | chr9:1501480-1501481 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35813592 | chr9:1501518-1501519 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs111687793 | chr9:1501522-1501523 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs528811988 | chr9:1501558-1501559 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs569009085 | chr9:1501593-1501594 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs537624288 | chr9:1501595-1501596 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551589985 | chr9:1501607-1501608 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7020606 | chr9:1501618-1501619 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ovarian cancer | 21720365 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Melanoma | 18172304 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Williams-beuren syndrome | 18553513 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Pilocytic astrocytoma | 18622384 | CNVD |
Pilomyxoid astrocytoma | 18622384 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
prenatal diagnosis | 20453657 | CNVD |
Gastric cancer | 16715143 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 20531469 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 18632612 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:1491000-1504000 | Weak transcription | Adipose Nuclei | Adipose |
2 | chr9:1504000-1504800 | Strong transcription | Adipose Nuclei | Adipose |
3 | chr9:1504800-1513800 | Weak transcription | Adipose Nuclei | Adipose |
4 | chr9:1511000-1511200 | Enhancers | NHEK | skin |
5 | chr9:1512600-1513000 | Enhancers | Fetal Muscle Leg | muscle |
6 | chr9:1512800-1514200 | Enhancers | NHEK | skin |
7 | chr9:1513000-1513400 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr9:1513000-1513800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
9 | chr9:1513200-1514000 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
10 | chr9:1513400-1514800 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr9:1513800-1514600 | Enhancers | Adipose Nuclei | Adipose |